Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy
2022 · Gastric Cancer · 104 citations
https://doi.org/10.1007/s10120-022-01301-0
J
Joe Yeong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
1.8K
Citations
17
h-index
25
i10-index
Joe Yeong is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Single-cell and spatial transcriptomics & Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics. The author has an h-index of 17, co-authored 72 publications.
Papers by this author
worksQuantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients
2020 · Breast Cancer Research · 36 citations
https://doi.org/10.1186/s13058-020-01282-x
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
2025 · Journal for ImmunoTherapy of Cancer · 28 citations
https://doi.org/10.1136/jitc-2024-010928
Clinical implications of systemic and local immune responses in human angiosarcoma
2021 · npj Precision Oncology · 13 citations
https://doi.org/10.1038/s41698-021-00150-x
Additional file 2: of A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3696271_d2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat